Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers

Molecular and Cellular Biology

Volumn 19, Issue 1, 1999, Pages 612-622

  Gudas, Jean M ^a   Payton, Marc ^a   Thukral, Sushil ^a   Chen, Eddy ^a   Bass, Michael ^a   Robinson, Murray O ^a   Coats, Steve ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE;

ARTICLE; CANCER; CELL CYCLE; CELL PROLIFERATION; GENE SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032931766     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.1.612     Document Type: Article

References (43)

1. Arends, M. J., C. H. Buckley, and M. Wells. 1998. Aetiology, pathogenesis and pathology of cervical neoplasias. J. Clin. Pathol. 51:96-103.
2. Brugarolos, J., R. T. Bronson, and T. Jacks. 1998. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J. Cell Biol. 141:503-504.
3. Kip1 protein: prognostic implications in primary breast cancer. Nat. Med. 3:227-230.
4. Clurman, B. E., R. Sheaff, K. Thress, M. Groudine, and J. M. Roberts. 1996. Cdk2-dependent cyclin E ubiquitination. Genes Dev. 10:1979-1990.
5. Ethier, S. P., M. L. Mahacek, W. J. Gullick, T. S. Frank, and B. L. Weber. 1993. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites. Cancer Res. 53:627-635.
6. Evans, T., E. Rosenthal, J. Youngblom, D. Distel, and T. Hunt. 1983. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33:389-396.
7. Gray-Bablin, J., J. Zalvide, M. Fox, C. Knickerbocker, J. DeCaprio, and K. KeyoMarsi. 1996. Cyclin E, a redundant cyclin in breast cancer. Proc. Natl. Acad. Sci. USA 93:15215-15220.
8. Gudas, J. M., G. B. Knight, and A. B. Pardee. 1988. Nuclear posttranscriptional processing of thymidine kinase mRNA at the onset of DNA synthesis. Proc. Natl. Acad. Sci. USA 85:4705-4709.
9. Hao, M., A. Lowy, M. Kapoor, A. Deffie, G. Liu, and G. Lozano. 1996. Mutation of phosphoserine 389 affects p53 function in vivo. J. Biol. Chem. 217:29380-29385.
10. 1 restriction point control in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402-2407.
11. Horowitz, J. M., S. H. Park, E. Bogenmann, J. C. Cheng, D. W. Yandell, F. J. Kaye, J. D. Minna, T. P. Dryja, and R. A. Weinberg. 1990. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA 87:2775-2779.
12. Horton, L., and D. Templeton. 1997. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity. Oncogene 14:491-498.
13. Jones, D. L. 1996. Interactions of the human papillomavirus E7 protein. Semin. Cancer Biol. 7:327-337.
14. Keyomarsi, K., N. O'Leary, G. Molnar, E. Lees, H. J. Fingert, and A. B. Pardee. 1994. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res. 54:380-385.
15. Kelly, B., K. Wolfe, and J. Roberts. 1998. Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein. Proc. Natl. Acacl. Sci. USA 95:2535-2540.
16. Koff, A., F. Cross, A. Fisher, J. Schumacher, K. Leguellec, M. Philippe, and J. Roberts. 1991. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66:1217-1228.
17. 1 phase of the human cell cycle Science 257:1689-1694.
18. Lew, D. J., V. Dulic, and S. Reed. 1991. Isolation of three novel human cyclin by rescue of G1 cyclin (Cln) function in yeast. Cell 66:1197-1206.
19. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
20. Lundberg, A. S., and R. Weinberg. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753-761.
21. Masiakowski, P., R. Breathnach, J. Bloch, F. Gannon, A. Krust, and P. Chambon. 1982. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10:7895-7903.
22. Minshull, J., R. Golsteyn, C. Hill, and T. Hunt. 1990. The A- and B-type cyclin associated cdc2 kinases in Xenopus turn on and off at different times in the cell cycle. EMBO J. 9:2865-2875.
23. Morgan, D. O. 1996. The dynamics of cyclin dependent kinase structure. Curr. Opin. Cell Biol. 8:767-772.
24. Mumberg, U., M. Wick, C. Burger, K. Haas, M. Funk, and R. Muller. 1997. Cycline Et, a new splice variant of human cyclin E with a unique expression pattern during cell cycle progression and differentiation. Nucleic Acids Res. 25:2098-2105.
25. Ohtsubo, M., and J. Roberts. 1993. Cyclin-dependent regulation of G1, in mammalian fibroblasts. Science 259:1908-1912.
26. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
27. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med. 3:222-225.
28. Price, B. D., L. Hughes-Davies, and S. Park. 1995. Cdk2 kinase phosphorylates serine 315 of human p53 in vitro. Oncogene 11:73-80.
29. 1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
30. Kip1 cyclin-dependent-kinase inhibitor bound to the cydin A-Cdk2 complex. Nature 382:325-331.
31. Cip1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol. Cell. Biol. 17:4338-4345.
32. Sarcevic, B., R. Lilischkis, and R. Sutherland. 1997. Different phosphorylation of T-47D breast cancer cell substrates by D1-. D3-. E-. and A-type cydin-CDK complexes. J. Biol. Chem. 272:33327-33337.
33. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
34. Sherr, C., and J. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
35. Slingerland, J. M., L. Hengst, C.-H. Pan, D. Alexander, M. R. Stampfer, and S. I. Reed. 1994. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol. Cell. Biol. 14:3683-3694.
36. Soule, H. D., T. M. Maloney, S. R. Wolman, W. D. Peterson, Jr., R. Brenz, C. M. McGrath, J. Russo, R. J. Pauley, R. F. Jones, and S. C. Brooks. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line. Cancer Res. 50:6075-6086.
37. Thukral, S., G. Blain, K. Chang, and S. Fields. 1994. Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2. Mol. Cell. Biol. 14:8315-8321.
38. Tyers, M., G. Tokiwa, and B. Futcher. 1993. Comparison of the Saccharomyces cerevisiae G1 cyclins: cln3 may be an upstream activator of cln1, cln2 and other cyclins. EMBO J. 12:1955-1968.
39. Vasudevan, D. M., and T. Vijayakumar. 1998. Viruses in human oral cancers. J. Exp. Clin. Cancer Res. 17:27-31.
40. Wang, Y., and C. Prives. 1995. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376:88-91.
41. Won, K., and S. Reed. 1996. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15:4182-4193.
42. Zhao, J., B. Dynlacht, T. Imai, T. Hori, and E. Harlow. 1998. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev. 12:456-461.
43. Cip1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 9:1740-1752.